Hananja

Manufacturing Authorisation

E-mail Print PDF

In January 2014, Hananja received manufacturing authorisation from the Icelandic Medicines Agency, allowing the company to manufacture and distribute aspirin and placebo tablets for the preeclampsia clinical trial (ASPRE) in pregnant women. The trials will be carried out in various hospitals around Europe, such as King's College Hospital in London. The trial are planned to start in April 2014.

 
Þú ert hér: Home

Support center

Hananja plc

  • Address: Aflagrandi 7
  • City: 107 Reykjavík, Iceland
  • Tel: (+354) 898-0318
  • Email: sg@hananja.com